Testing a jaw movement sensor to diagnose obstructive sleep apnoea
Compares Sunrise with usual tests for suspected obstructive sleep apnoea.
Key facts
- Who runs it
- Virginia Hawkins
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- A Study Assessing Adult Patients Referred to an NHS Sleep Service With Suspected Obstructive Sleep Apnoea. This Study Aims to Compare the Sunrise Wearable Diagnostic Device Performance and Potential Inclusion in a NHS Diagnostic Pathway With Oximetry and WatchPAT Which Are Currently Used.
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 28 Jul 2025
- Planned end
- 30 Sept 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- WatchPAT 300
- Oximetry
- Sunrise
- Record updated
- 19 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults sent to an NHS sleep clinic because doctors think they may have obstructive sleep apnoea. Participants wear the Sunrise jaw-movement device for one night alongside their usual sleep test.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Suspected obstructive sleep apnoea (OSA), referred to a sleep clinic as an outpatient
Main reasons for not taking part
- Suspected other sleep disorder, such as central sleep apnoea, parasomnias, narcolepsy or idiopathic hypersomnia
- Suspected long-term breathing failure with raised carbon dioxide (CO2) or serum bicarbonate
- Unstable heart or blood vessel disease, or non-arteritic anterior ischaemic optic neuropathy
- Conditions affecting jaw joint movement, or a beard below the lip the person will not shave
- Referred while staying in hospital, or no smartphone with Bluetooth and WiFi or internet data
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- • Adults (aged ≥18 years old) referred with suspected Obstructive Sleep Apnoea; Patient has capacity to provide informed consent; Patient has access to a smartphone with Bluetooth and WiFi or internet data to download the Sunrise app and to transmit the Sunrise results to the Sunrise portal. UHBW Trust Wi-Fi available to the patient at equipment collection and return if needed; Willing and able to comply with the study-specific procedures; Ability to read and comprehend English or understand simple device user instructions with guided pictures in English
Who cannot take part
- • Suspected diagnosis of a sleep disorder other than OSA (including central sleep apnoea, parasomnias, narcolepsy, idiopathic hypersomnia); Suspected chronic hypercapnic respiratory failure (history of acute hypercapnic respiratory failure, raised CO2 or serum bicarbonate); Patients with unstable cardiovascular disease or non-arteritic anterior ischaemic optic neuropathy; Patients with beards who are unwilling to shave the area below their lip (the soul patch); Patients with conditions affecting the rotation of the condyle in the temporo-mandibular joint; Unable to consent or lacks capacity to provide informed consent; In-patient referrals; Unwilling or unable to comply with the study-specific procedures; Patients who have requested in their medical notes not to be involved in research or not to receive digital communication
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether the Sunrise device (that measure small jaw movements) can improve the diagnosis and management of Obstructive Sleep Apnoea (OSA) in adults (≥ 18 years) referred to a Sleep Clinic.
Read full original descriptionShow less
The main question it aims to answer are:
- Does Sunrise lead to a higher proportion of definitive management decisions (initiate OSA treatment, discharge from the sleep clinic service, additional diagnostic testing required or a clinic appointment) compared to current screening practices, which includes either overnight oximetry or use of a wearable device called WatchPAT 300?
Researchers will compare Sunrise results with oximetry and WatchPAT 300 outcomes to see if Sunrise improves diagnostic efficiency, reduces time to a diagnosis or clinical decision and enhances patient experience.
Participants will:
* Follow the standard clinical pathway (oximetry or WatchPAT 300) * Use the Sunrise device simultaneously for one night with their usual test * Complete a patient feedback questionnaire on ease of use and experience * Return all equipment two days later, Sunrise results will not affect their clinical care and will be used for the study only
The 2 groups in the trial
- WatchPAT 300Treatment being tested
WatchPAT 300 and Sunrise
Treatment: WatchPAT 300 and Sunrise
- OximetryTreatment being tested
Oximetry and Sunrise
Treatment: Oximetry and Sunrise
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sunrise in Obstructive Sleep Apnoea Study (SOSA) A Comparison of the Sunrise Mandibular Movement Monitoring Device With Overnight Oximetry and WatchPAT in the Diagnosis and Management of Obstructive Sleep Apnoea.
- Plain-language title
- Testing a jaw movement sensor to diagnose obstructive sleep apnoeaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 19 December 2025